Tactile Systems Technology develops and markets at-home medical devices for chronic swelling conditions, notably lymphedema and related vascular disorders. Its flagship pneumatic compression systems, including Flexitouch, deliver prescribed sequential therapy that patients can use outside clinical settings. The company focuses on clinically supported, prescription-based solutions sold through U.S. healthcare channels to improve long-term symptom management.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 78.9 | — | 3.2 | -32.3% |
| Q3 2025 | 85.8 | — | 8.2 | 37% |
| Q4 2025 | 103.6 | — | 10.6 | 10.8% |
| Q1 2026 | 75.3 | — | -1.8 | — |
| Q2 2026 | 85.7 | 8.6% | 7.8 | 142% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Factorial Energy Inc. (FAC), Forward Air Corporation (FWRD), Puma Biotechnology, Inc. (PBYI), SS Innovations International, Inc. (SSII), Bright Minds Biosciences Inc. (DRUG), Powerlaw Corp. (PWRL)